Adel Zaatar

655 citations
9 papers · 476 · 1 hit paper · h-index 5

Impact in

  • Oncology top 10%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Gastric Cancer Management and Outcomes

Papers in

    • Colorectal Cancer Treatments and Studies 6
    • Cancer Treatment and Pharmacology 2
    • Peptidase Inhibition and Analysis 1
    • Lung Cancer Treatments and Mutations 6
    • Gastric Cancer Management and Outcomes 2

Adel Zaatar

9 papers receiving 471 citations

Adel Zaatar's Hit Papers

Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis 2013 · 383 citations
3830+4+8Years since publication100200300

Peers

Adel Zaatar
Comparison fields: 5 of 43
  • Oncology 328
  • Pulmonary and Respiratory Medicine 376
  • Cancer Research 105
  • Molecular Biology 126
  • Pathology and Forensic Medicine 26
Replace Feiyu Niu with:
Feiyu Niu China
Changli Wang China
Jane Bromund United States
Shanbo Zheng China
Kevin Jao Canada
Zhenkui Pan China
Neelam Shah United States
Alessandro Gamboni Italy
D. Chu China
Eamon M. Berge United States
Adel Zaatar relative to Feiyu Niu China Feiyu Niu's profile →
Citations per field
00.5×1.5×1.8×
Feiyu Niu · 1×
Citations per year

Countries citing papers authored by Adel Zaatar

Since Specialization
Citations

This map shows the geographic impact of Adel Zaatar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Zaatar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Zaatar more than expected).

Fields of papers citing papers by Adel Zaatar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel Zaatar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Zaatar. The network helps show where Adel Zaatar may publish in the future.

Co-authors

The 25 scholars most cited alongside Adel Zaatar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adel Zaatar Line = papers co-authored together Adel Zaatar links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
Hit paper breakdown →
2013383
2 201936
3 201227
4 201217
5 20166
6 20134
7 20191
8 20161
9 20151

About Adel Zaatar

Adel Zaatar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Organic Chemistry, having authored 9 papers that have together received 476 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Treatment and Pharmacology (2 papers), Gastric Cancer Management and Outcomes (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer-related molecular mechanisms research (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Oncology (328 citations), Pulmonary and Respiratory Medicine (376 citations), Cancer Research (105 citations), Molecular Biology (126 citations) and Pathology and Forensic Medicine (26 citations). Adel Zaatar has collaborated with scholars based in Taiwan, Australia and Singapore. Frequent co-authors include Chris Brown, Sumitra Thongprasert, Siow Ming Lee, Val Gebski, Richard J. Gralla, D. Chu, James Chih‐Hsin Yang, Jcm Ho, Chee Khoon Lee and Vera Hirsh. Their work appears in journals such as Annals of Oncology, JNCI Journal of the National Cancer Institute, Journal of Thoracic Oncology, Lung Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact